Detection of adverse drug reactions through the minimum basic data set

Pharmacy World and Science

Volumn 32, Issue 3, 2010, Pages 322-328

  Salmerón García, Antonio ^a   Cabeza Barrera, José ^a   Vergara Pavón, Maria José ^a   Román Márquez, Eva ^b   Cortés De Miguel, Sol ^a   Vallejo Rodríguez, Inmaculada ^a   Raya García, Susana ^a   Casado Fernández, Emilia ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Inmaculada Regional Hospital   (Spain)

Author keywords

ADR reporting systems; Adverse drug reactions; Drug surveillance systems; Hospital; Minimum basic data set; Pharmacovigilance; Spain

Indexed keywords

ABACAVIR; ADALIMUMAB; ALLOPURINOL; ALPRAZOLAM; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BOSENTAN; CARBAMAZEPINE; CARDIOVASCULAR AGENT; COZAAR PLUS; DIGITALIS GLYCOSIDE; DILTIAZEM; EFALIZUMAB; IMATINIB; IMMUNOSUPPRESSIVE AGENT; IOMEPROL; LACEROL RETARD; LINEZOLID; LOSARTAN POTASSIUM; METILDIGOXIN; PARACETAMOL; PEGINTERFERON ALPHA2A; PNEUMOCOCCUS VACCINE; PREGABALIN; PREVANAR; PROPOFOL; TACROLIMUS; TETRAZEPAM; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANEMIA; ANGIONEUROTIC EDEMA; ARTICLE; BRONCHOSPASM; DATA COLLECTION METHOD; DESCRIPTIVE RESEARCH; DIGITALIS INTOXICATION; DRUG ERUPTION; DRUG SURVEILLANCE PROGRAM; ERYTHEMA; HOSPITAL PATIENT; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; INCIDENCE; INTERMETHOD COMPARISON; INTESTINE ISCHEMIA; JAUNDICE; LIVER DISEASE; PAPULOMACULAR ERYTHEMA; PAPULOMACULAR RASH; PEMPHIGUS FOLIACEUS; POLYNEUROPATHY; PRURITUS; RETINOPATHY; RETROSPECTIVE STUDY; SEX RATIO; SPAIN; TONIC CLONIC SEIZURE; TOXIC EPIDERMAL NECROLYSIS; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT; URTICARIA; VOMITING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATABASES, FACTUAL; DRUG TOXICITY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICATION SYSTEMS, HOSPITAL; RETROSPECTIVE STUDIES; SPAIN;

EID: 77953324729     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9372-2     Document Type: Article

References (32)

1. The World Health Organization. The importance of pharmacovigilance. Safety monitoring of medicinal products. Geneva: WHO; 2002. ISBN 92 4 1590157.
2. N Moore D Montero R Coulson FJ de Abajo C Kreft-Jais A Biron, et al. 1994 Communication in drug surveillance Pharmacoepidemiol Drug Saf 3 151 155 10.1002/pds.2630030305
3. H Patel D Bell M Molokhia J Srishanmuganathan M Patel J Car A Majeed 2007 Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005 BMC Clin Pharmacol 7 9 10.1186/1472-6904-7-9 17894876 (Pubitemid 350177224)
4. International Drug Monitoring: The Role of National Centres. World Health Organization. Technical Report Series 498. Geneva: World Health Organization; 1972.
5. th, which regulated the drug surveillance of medicines for human use. Boletín Oficial del Estado, no 262, of November 1st, 2007, Madrid (Document on the internet); 2007 (cited 2009 May 30). http://www.boe.es/aeboe/consultas/bases-datos/doc.php?id=BOE-A- 2007-18919.
6. The Uppsala Monitoring Centre (the UMC), WHO Collaborating Centre for International Drug Monitoring, Uppsala (homepage on the Internet); 2009 (cited 2009 May 30). http://www.who-umc.org.
7. M Irujo G Beitia M Bes-Rastrollo A Figueiras S Hernández- Díaz B Lasheras 2007 Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region Drug Saf 30 1073 1082 10.2165/00002018-200730110-00006 17973543
8. AC Van Grootheest EP van Puijenbroek LT den Berg 2002 Contribution of pharmacists to the reporting of adverse drug reactions Pharmacoepidemiol Drug Saf 11 205 210 10.1002/pds.702 12051119 (Pubitemid 34537526)
9. SR Ahmad JP Freiman DJ Graham RC Nelson 1996 Quality of adverse drug experience reports submitted by pharmacists and physicians to the FDA Pharmacoepidemiol Drug Saf 5 1 7 1:STN:280:DC%2BD2c7pt1Sjug%3D%3D 15088271
10. K Van Grootheest S Olsson M Couper L den Berg 2004 Pharmacists' role in reporting adverse drug reactions in an international perspective Pharmacoepidemiol Drug Saf 13 457 464 10.1002/pds.897 15269929 (Pubitemid 38996856)
11. Ministerial Order of 6 September 1984 establishing the obligation for a hospital discharge report for all patients. B.O.E. no 221 of 14 September; 1984.
12. J Torelló 2001 Role of the MBDS in drug surveillance. Advantages and limitations of an underused tool Arch Fac Med Zaragoza 41 Supll I 24 28
13. JM Sotoca N Corominas C Codina J Ribas 2006 Efectos adversos a medicamentos detectados a través del conjunto mínimo básico de datos de las altas hospitalarias. (Adverse drug-related effects detected across the minimaum basic data set at the hospital discharges) El Farmacéutico Hospitales 174 5 7
14. LA Sánchez Muñoz J Castiella Herrero FJ Sanjuán Portugal J Naya Manchado MJ Alfaro Alfaro 2007 Usefulness of MBDS in detection of adverse drug events An Med Interna 24 113 119 17590131
15. S Corral Baena MD Guerrero Aznar M Beltrán García J Salas Turrens 2004 Use of MBDS as a tool for the detection of drug-related adverse events Farm Hosp 28 258 265 1:STN:280:DC%2BD2cvptFCisg%3D%3D 15369436
16. CE Leonard K Haynes AR Localio S Hennessy J Tjia A Cohen, et al. 2008 Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events J Clin Epidemiol 61 561 571 10.1016/j.jclinepi.2007.08.003 18471660
17. Castillo JR, Merino N, Bejarano MD, Domínguez JC, Fernández G, García J, et al. Results of the program of spontaneous notification of adverse reactions in Andalusia. Year 2006. Alert Drug Surveill 2007; 36:13-16.
18. E Heeley J Riley D Layton L Wilton S Shakir 2001 Prescription event monitoring and reporting of adverse drug reactions Lancet 358 1872 1873 10.1016/S0140-6736(01)06898-2 1:STN:280:DC%2BD3MjgtVClsQ%3D%3D 11741629 (Pubitemid 34008656)
19. Aguirre C. Utilization of the hospital MBDS as a source of information in drug surveillance. Summary Book of the III Day Conference on Drug Surveillance, Toledo (document on the internet); 2002 [cited 2009 May 30]. Available from: http://www.jccm.es/sanidad/reuniones/farmacovigilancia/libro.pdf.
20. R Colville J Laing M Murison 2000 Coding plastic surgery operations: an audit of performance using OPCS-4 Br J Plast Surg 53 420 422 10.1054/bjps.2000.3323 1:STN:280:DC%2BD3MzltlSisg%3D%3D 10876282 (Pubitemid 30479649)
21. P Waller M Shaw D Ho S Shakir S Ebrahim 2004 Hospital admissions for drug induced disorders in England: a study using the Hospital Episodes Statistics (HES) database Br J Clin Pharmacol 59 213 219 10.1111/j.1365-2125.2004.02236.x
22. D Budnitz D Pollock K Weidenbach, et al. 2006 National Surveillance of emergency department visits for outpatients adverse drug events JAMA 296 1858 1866 10.1001/jama.296.15.1858 1:CAS:528:DC%2BD28XhtFWmsL%2FN 17047216
23. CL Burgess CD Holman AG Satti 2005 Adverse drug reactions in older Australians, 1981-2002 Med J Aust 182 267 270 15777140
24. F Caamano C Pedone G Zuccala P Carbonin 2005 Sociodemographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population Arch Gerontol Geriatr 40 45 52 10.1016/j.archger.2004.05.005 15531022 (Pubitemid 39505211)
25. J Lazarou BH Pomeranz PN Corey 1998 Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies JAMA 279 1200 1205 10.1001/jama.279.15.1200 1:STN:280:DyaK1c3hsFSnsQ%3D%3D 9555760 (Pubitemid 28193431)
26. M Pirmohamed S James S Meakin C Green AK Scott TJ Walley, et al. 2004 Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients BMJ 329 15 19 10.1136/bmj.329.7456.15 15231615 (Pubitemid 38869995)
27. C Kongkaew P Noyce D Ashcroft 2008 Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies Ann Pharmacother 42 1017 1025 10.1345/aph.1L037 18594048
28. R Romero del Barco R Ferrando E Soler MA Blázquez A González M Vilella 2008 Detection and analysis of adverse drug-related events across the minimum basic data set Atención Farm Eur J Clin Pharm 10 143 146
29. DM Fick JW Cooper WE Wade JL Waller JR Maclean MH Beers 2003 Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts Arch Intern Med 163 2716 2724 10.1001/archinte.163.22.2716 14662625 (Pubitemid 37517412)
30. R Wright SM Handler C Ruby JT Hanlon 2006 Update on drug-related problems in the elderly Am J Geriatr Pharmacother 4 78 84 10.1016/j.amjopharm.2006.03. 009 (Pubitemid 44225989)
31. K Brøsen 2007 Sex differences in pharmacology Ugeskr Laeger 169 2408 2411 17594829
32. GD Anderson 2008 Gender differences in pharmacological response Int Rev Neurobiol 83 1 10 10.1016/S0074-7742(08)00001-9 18929073